Delivery Order SPE2DR25D1202-SPE2DR26F77FD
Award Date 4/17/26
Potential Completion Date 5/8/26
Potential Value $2.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,377.90 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for Rhophylac 300 mcg/2 ml syringes. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical commodities to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure and an ultimate...
- The Defense Logistics Agency issued a $1,377.90 delivery order to Amerisourcebergen Drug Corp on April 13, 2026, for Rhophylac 300 mcg/2 ml syringes under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX). The parent IDC, valued at $999,999,999.00 through December 2026, is a comprehensive global pharmaceutical support vehicle enabling Amerisourcebergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for Rhophylac 300 mcg/2 ml syringes with a ceiling value of $1,148.25 and firm fixed pricing. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order is...
- <p>The Defense Logistics Agency issued a $1,377.90 delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for Rhophylac 300 mcg/2 ml syringes under a firm fixed-price contract, with ultimate completion on January 29, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries no set-aside designation.</p>
- The Defense Logistics Agency awarded a $1,147.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under a larger contract vehicle. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rhophylac 300 mcg/2 mL syringes, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,388.40 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This firm fixed-price, competitively awarded contract calls for delivery to be completed by December 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,388.40 for Rhophylac 300 mcg/2 mL syringes under a firm fixed price contract. The award, issued December 31, 2025, with completion targeted for January 23, 2026, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $906.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The prime contractor will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of DLA programs. No major subcontractors or set aside designations were indicated. DLA manages the global supply chain for the United States Department of Defense, procuring critical medical...
- The Defense Logistics Agency awarded a $453,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the specified medication from its facility in Conshohocken, Pennsylvania by October 18, 2023 to support DLA's mission to provide medical supplies and...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F77FDDelivery Order
The Defense Logistics Agency issued a $2,204.64 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for Rhophylac 300 mcg/2 ml syringe (2 ml). Place of performance is Conshohocken, PA. The order has a completion date of May 8, 2026, and carries firm fixed-price terms with no set-aside. The parent vehicle is a single-award indefinite delivery contract with the Defense Logistics Agency supporting the Pharmaceutical Prime Vendor Global Program Generation V, valued at $4.999 million through December 2036, which supplies brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to military healthcare systems worldwide.
Generated 7/16/26, 10:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/16/26 |